Tofacitinib, a novel JAK3 inhibitor, as a potential cause of distal symmetric polyneuropathy.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY(2016)

Cited 4|Views4
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined